PHC Holdings

Lunaphore offers solutions based on a chip technology that can extract spatial proteomic and transcriptome data from tumors and other tissues, transforming any assay into multiplex spatial biology with an easy-to-use interface. Lunaphore enables immunology, immuno-oncology, and neurology researchers to push the boundaries of scientific discovery and therapeutic development. Lunaphore's technology identifies clinically relevant biomarker "signatures" to aid in the development of diagnostic tools and to streamline clinical trials, ultimately improving patient outcomes.

Lunaphore offers solutions based on a chip technology that can extract spatial proteomic and transcriptome data from tumors and other tissues, transforming any assay into multiplex spatial biology with an easy-to-use interface. Lunaphore enables immunology, immuno-oncology, and neurology researchers to push the boundaries of scientific discovery and therapeutic development. Lunaphore's technology identifies clinically relevant biomarker "signatures" to aid in the development of diagnostic tools and to streamline clinical trials, ultimately improving patient outcomes.

Aiforia Technologies was founded as a spin-off company from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki in 2013 by researchers and pioneers in the field of cloud-based microscopy and pathology and experienced life science entrepreneurs. The Aiforia® Platform brings together deep learning AI and high-performance cloud computing. Aiforia assists with the increased demand for image-based diagnostics by providing efficient and scalable solutions – enabling new discoveries and clinical support with highly accurate and consistent data. Aiforia is technologically driven establishment and keeps the capability of being image agnostic thus extending its solutions to multiple fields.

Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.

Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring ("CGM") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.

Lunaphore offers solutions based on a chip technology that can extract spatial proteomic and transcriptome data from tumors and other tissues, transforming any assay into multiplex spatial biology with an easy-to-use interface. Lunaphore enables immunology, immuno-oncology, and neurology researchers to push the boundaries of scientific discovery and therapeutic development. Lunaphore's technology identifies clinically relevant biomarker "signatures" to aid in the development of diagnostic tools and to streamline clinical trials, ultimately improving patient outcomes.

KAKEHASHI is the opportunity of Their foundation to want to become "Kakehashi connecting medical treatment and patients" "Kakehashi connecting medical care with a bright future". Japan is a country possessing world-class medical technology and medical system, it is a country with prominent longevity to be proud of in the world. In 2060, one in 2.5 people will enter an unprecedented super aging society of 65 years old and over, one in four will be over 75 years old. To think about the way of medical care that supports the healthy life expectancy in Japan is nothing but creation of the future image of Japanese society.

Ascensia Diabetes Care is a global company dedicated to improving the lives of people with diabetes and helping empower them to take charge of their health and happiness.

Millennial Net's flagship platform, MeshScape, offers highly scalable, low power, reliable wireless mesh networking capability that is beyond any conventional WSN technologies. Millennial Net also provides Wireless Energy Management and Energy Efficiency solutions focused on commercial and public building applications. Typically save 15%-30% of a buildings current energy consumption.